Veterinary Medicines

GALLIVAC IBD, gyva liofilizuota vakcina

Not authorised
  • Infectious bursal disease virus, strain S706, Live
Download as PDF

Product identification

Medicine name:
GALLIVAC IBD, gyva liofilizuota vakcina
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken
Route of administration:
  • Ocular use
  • Beak dipping
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    10000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Ocular use
    • Chicken
      • Meat and offal
        0
        day
  • Beak dipping
    • Chicken
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Surrendered
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/95/0248/001-004
Date of authorisation status change:

Documents

RV0248.pdf

Lithuanian (PDF)
Published on: 10/06/2022
Download